ゼリア新薬工業の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2013/03/07 | 1,440 | 1,448 | 1,440 | 1,447 | +1 | +0.1% | 10,000 |
| 2013/03/06 | 1,435 | 1,449 | 1,435 | 1,446 | +13 | +0.9% | 13,000 |
| 2013/03/05 | 1,417 | 1,433 | 1,417 | 1,433 | +16 | +1.1% | 14,000 |
| 2013/03/04 | 1,410 | 1,428 | 1,408 | 1,417 | +5 | +0.4% | 12,000 |
| 2013/03/01 | 1,400 | 1,413 | 1,400 | 1,412 | +12 | +0.9% | 20,000 |
| 2013/02/28 | 1,399 | 1,400 | 1,398 | 1,400 | +7 | +0.5% | 21,000 |
| 2013/02/27 | 1,398 | 1,398 | 1,390 | 1,393 | -5 | -0.4% | 12,000 |
| 2013/02/26 | 1,386 | 1,403 | 1,386 | 1,398 | -18 | -1.3% | 17,000 |
| 2013/02/25 | 1,412 | 1,416 | 1,412 | 1,416 | +4 | +0.3% | 26,000 |
| 2013/02/22 | 1,400 | 1,417 | 1,395 | 1,412 | -10 | -0.7% | 25,000 |
| 2013/02/21 | 1,420 | 1,426 | 1,420 | 1,422 | +2 | +0.1% | 18,000 |
| 2013/02/20 | 1,398 | 1,420 | 1,398 | 1,420 | +30 | +2.2% | 24,000 |
| 2013/02/19 | 1,387 | 1,393 | 1,386 | 1,390 | +12 | +0.9% | 12,000 |
| 2013/02/18 | 1,378 | 1,378 | 1,376 | 1,378 | ±0 | ±0% | 9,000 |
| 2013/02/15 | 1,380 | 1,387 | 1,376 | 1,378 | -4 | -0.3% | 15,000 |
| 2013/02/14 | 1,384 | 1,395 | 1,381 | 1,382 | +2 | +0.1% | 14,000 |
| 2013/02/13 | 1,376 | 1,385 | 1,376 | 1,380 | -2 | -0.1% | 10,000 |
| 2013/02/12 | 1,379 | 1,389 | 1,379 | 1,382 | +7 | +0.5% | 16,000 |
| 2013/02/08 | 1,388 | 1,388 | 1,375 | 1,375 | -13 | -0.9% | 14,000 |
| 2013/02/07 | 1,389 | 1,410 | 1,380 | 1,388 | -13 | -0.9% | 20,000 |
| 2013/02/06 | 1,404 | 1,410 | 1,401 | 1,401 | -16 | -1.1% | 17,000 |
| 2013/02/05 | 1,430 | 1,430 | 1,417 | 1,417 | -23 | -1.6% | 10,000 |
| 2013/02/04 | 1,444 | 1,445 | 1,437 | 1,440 | -8 | -0.6% | 9,000 |
| 2013/02/01 | 1,436 | 1,448 | 1,436 | 1,448 | +12 | +0.8% | 18,000 |
| 2013/01/31 | 1,442 | 1,446 | 1,436 | 1,436 | -10 | -0.7% | 15,000 |
| 2013/01/30 | 1,430 | 1,446 | 1,430 | 1,446 | +16 | +1.1% | 13,000 |
| 2013/01/29 | 1,426 | 1,440 | 1,424 | 1,430 | +3 | +0.2% | 14,000 |
| 2013/01/28 | 1,432 | 1,445 | 1,423 | 1,427 | +9 | +0.6% | 29,000 |
| 2013/01/25 | 1,403 | 1,418 | 1,395 | 1,418 | +18 | +1.3% | 25,000 |
| 2013/01/24 | 1,377 | 1,400 | 1,376 | 1,400 | +19 | +1.4% | 16,000 |
| 2013/01/23 | 1,382 | 1,385 | 1,371 | 1,381 | -1 | -0.1% | 13,000 |
| 2013/01/22 | 1,407 | 1,409 | 1,382 | 1,382 | -51 | -3.6% | 21,000 |
| 2013/01/21 | 1,437 | 1,437 | 1,420 | 1,433 | -4 | -0.3% | 15,000 |
| 2013/01/18 | 1,400 | 1,440 | 1,400 | 1,437 | +42 | +3% | 18,000 |
| 2013/01/17 | 1,389 | 1,400 | 1,386 | 1,395 | +15 | +1.1% | 11,000 |
| 2013/01/16 | 1,380 | 1,380 | 1,380 | 1,380 | -6 | -0.4% | 1,000 |
| 2013/01/15 | 1,390 | 1,400 | 1,383 | 1,386 | -3 | -0.2% | 18,000 |
| 2013/01/11 | 1,410 | 1,415 | 1,378 | 1,389 | -21 | -1.5% | 24,000 |
| 2013/01/10 | 1,436 | 1,436 | 1,410 | 1,410 | -26 | -1.8% | 20,000 |
| 2013/01/09 | 1,417 | 1,439 | 1,412 | 1,436 | +16 | +1.1% | 15,000 |
| 2013/01/08 | 1,431 | 1,433 | 1,420 | 1,420 | -18 | -1.3% | 20,000 |
| 2013/01/07 | 1,453 | 1,453 | 1,438 | 1,438 | -15 | -1% | 11,000 |
| 2013/01/04 | 1,432 | 1,459 | 1,432 | 1,453 | +22 | +1.5% | 28,000 |
| 2012/12/28 | 1,449 | 1,450 | 1,430 | 1,431 | -4 | -0.3% | 26,000 |
| 2012/12/27 | 1,420 | 1,442 | 1,420 | 1,435 | +17 | +1.2% | 20,000 |
| 2012/12/26 | 1,425 | 1,431 | 1,418 | 1,418 | +10 | +0.7% | 8,000 |
| 2012/12/25 | 1,450 | 1,450 | 1,385 | 1,408 | -10 | -0.7% | 32,000 |
| 2012/12/21 | 1,413 | 1,420 | 1,399 | 1,418 | +5 | +0.4% | 18,000 |
| 2012/12/20 | 1,398 | 1,413 | 1,380 | 1,413 | -15 | -1.1% | 17,000 |
| 2012/12/19 | 1,390 | 1,435 | 1,388 | 1,428 | +41 | +3% | 17,000 |
3051～
3100
件表示中 / 3771件
類似銘柄と比較する
現在ご覧いただいている「ゼリア新薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| ゼリア新薬 | 203,800円 | +3.1% | -6.5% | 2.36% | 9.46倍 | 1.00倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
| ジーエヌアイ | 264,000円 | +21.7% | +999.9% | 0.00% | 12.17倍 | 4.16倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
| 持田薬 | 316,000円 | +5.1% | -7.0% | 2.53% | 20.75倍 | 0.85倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
| 栄研化 | 249,200円 | +4.1% | -3.1% | 2.33% | 21.65倍 | 1.89倍 |
|
臨床検査薬大手。便潜血検査試薬（ＦＩＴ）はシェア７割。尿検査（ウロ）、遺伝子検査も育成 |
| 杏林製薬 | 151,800円 | -2.4% | -52.3% | 3.75% | 18.17倍 | 0.64倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
市場注目の銘柄
チャート関連のコラム
